Record #22480
Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
Publisher
Original paper date
Aug 28, 2019
Original DOI
Country
Institution
State Key Laboratory of Natural Medicines, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China · The Engineering Research Center of Synthetic Polypeptide Drug Discovery and Evaluation of Jiangsu Province, Nanjing, 211198, People’s Republic of China · Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, 3800, Australia
Open access
No
Article type
Broad categories
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
1
Post-retraction
5
% post-retraction
83.3%
~0.0 citations/yr before retraction · ~0.8 citations/yr after
— citing papers
Who is still citing this work
Loading…